DermTech (DMTK) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to DermTech (DMTK) Tops Q2 EPS by 2c

DermTech Reports Second-Quarter 2022 Financial Results; Company Updates Full-Year 2022 Outlook

August 8, 2022 4:01 PM EDT

LA JOLLA, Calif.--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported its second-quarter 2022 financial results and updated its full-year 2022 outlook.

We continued to set records for many of our key operating and financial metrics in the first half of 2022 despite numerous headwinds, said John Dobak, M.D., CEO, DermTech. Our sales and marketing team continues to be very effective in driving commercial traction, as evidenced by robust billable sample volume and new ordering clinician growth in the second... More